S.660 - PATIENTS Act of 2011

A bill to protect all patients by prohibiting the use of data obtained from comparative effectiveness research to deny or delay coverage of items or services under Federal health care programs and to ensure that comparative effectiveness research accounts for advancements in personalized medicine and differences in patient treatment response. view all titles (3)

All Bill Titles

  • Official: A bill to protect all patients by prohibiting the use of data obtained from comparative effectiveness research to deny or delay coverage of items or services under Federal health care programs and to ensure that comparative effectiveness research accounts for advancements in personalized medicine and differences in patient treatment response. as introduced.
  • Short: PATIENTS Act of 2011 as introduced.
  • Short: Preserving Access to Targeted, Individualized, and Effective New Treatments and Services (PATIENTS) Act of 2011 as introduced.

This Bill currently has no wiki content. If you would like to create a wiki entry for this bill, please Login, and then select the wiki tab to create it.

Bill’s Views

  • Today: 1
  • Past Seven Days: 1
  • All-Time: 2,159
 
Introduced
 
Senate
Passes
 
House
Passes
 
President
Signs
 

 
03/29/11
 
 
 
 
 
 
 

Official Summary

Preserving Access to Targeted, Individualized, and Effective New Treatments and Services (PATIENTS) Act of 2011 or the PATIENTS Act of 2011 - Prohibits the Secretary of Health and Human Services (HHS) from using data obtained from comparative effectiveness research, including such research

Official Summary

Preserving Access to Targeted, Individualized, and Effective New Treatments and Services (PATIENTS) Act of 2011 or the PATIENTS Act of 2011 - Prohibits the Secretary of Health and Human Services (HHS) from using data obtained from comparative effectiveness research, including such research that is conducted or supported using funds appropriated under the American Recovery and Reinvestment Act of 2009 (ARRA) or authorized or appropriated under the Patient Protection and Affordable Care Act, to deny or delay coverage of an item or service under a federal health care program. Requires the Secretary to ensure that comparative effectiveness research conducted or supported by the federal government accounts for factors contributing to differences in the treatment response and preferences of patients, including patient-reported outcomes, genomics and personalized medicine, the unique needs of health disparity populations, and indirect patient benefits.

...Read the Rest

Organizations Supporting S.660

  • American Medical Association

Organizations Opposing S.660

  • None via MapLight at this time.




Vote on This Bill

-% Users Support Bill

0 in favor / 0 opposed
 

Send Your Senator a Letter

about this bill Support Oppose Tracking
Track with MyOC